A new prognostic model could potentially predict and stratify the risk for hepatocellular carcinoma (HCC) among patients with chronic hepatitis B (CHB) who are noncirrhotic and not indicated for ...

Some 254 million people live with a chronic hepatitis B (HBV) infection that is often asymptomatic for decades, only to emerge in an advanced stage of disease that turns to fatal cirrhosis or liver ...

A new study published in Microbiology Spectrum reports the establishment of a liver-humanized NSG-PiZ mouse model that is fully permissive to hepatitis B virus (HBV) infection. In this model, HBV can ...

ELIMINATE-B Phase 1 dose finding study for chronic Hepatitis B executing on schedule with completion of first dose administration for cohort 1 (n=3 patients) PBGENE-HBV, the first LNP gene editing ...

In this study, researchers investigated the potential impacts of “shared decision-making” replacing universal HBV birth-dose vaccination on neonatal and later chronic HBV infections.

US model study suggests a targeted hepatitis B birth-dose strategy could increase neonatal infections unless screening and ...

A reliable HCC prediction model is essential for meeting the 2030 hepatitis elimination targets; however, existing risk scores have been derived from patients with active chronic hepatitis B infection ...

Around 260 million people, more than three percent of the global population, are chronically infected with the hepatitis B virus (HBV); in the long term, this often leads to complications such as ...

Delayed hepatitis B vaccination in infants whose birth parents tested negative for HBsAg is associated with adverse health outcomes.